Oncotarget has been publishing research papers that zero in on oncology and cancer research. In addition, the journal publishes papers concerning immunology, physiology, age-related diseases, pathology and endocrinology. To avert instances of plagiarism, falsification, fabrication, copyright infringement and defamation, Oncotarget follows a strict best-practices guideline.
Authors are encouraged to describe their results in an accurate manner and have an objective discussion of their work. Review articles should be comprehensive, objective and accurate. The manuscript should have detailed content and references to allow others to reproduce the work. Authors are obligated to identify perspective pieces or “editorial opinion.” Fraudulent information or inaccurate statements are considered unethical. Learn more about Oncotarget at Bioxbio.com.
Additionally, authors may be requested to avail raw data for purposes of editorial review. They should be ready to submit such information to the public if it is deemed practicable. For 7-10 years after publication, such data should be accessible by other competent professionals. Notably, participant’s confidentiality needs to be protected. Authors are expected to submit original works. To avoid plagiarism, they are encouraged to make appropriate citations. Publications that have played a pivotal role in influencing the work of an author should be cited.
Oncotarget prohibits authors from submitting manuscripts that have been published on other journals. Since authors take responsibility for their content, it is prudent to know the authorship criteria. An author is defined as one who made substantial contributions to the interpretation, design, conception and execution of the study, and acquisition of data. Another definition of an author is one who drafted and revised the manuscript for intellectual content. Lastly, he or she saw and acknowledged the final paper, and submitted it for publication.
At the time of submission, authors should disclose any conflict of interest that may influence the interpretation of their manuscript. For instance, they should talk about their employment, funding, honoraria, stock ownership, educational grants, patent-licensing arrangements and paid expert testimony. Correspondence, conversation and private discussion with third parties must not be used without written consent from the source. Authors should not use confidential information such as grant application and refereeing manuscripts unless they have written permission from the authors of such work. Authors are encouraged to disclose all sources of financial support, including any reference number and grant number. View more https://www.dovepress.com/oncotargets-and-therapy-journal